Side-by-side comparison of AI visibility scores, market position, and capabilities
Global #1 OTC ibuprofen brand owned by Haleon (LSE/NYSE: HLN, GSK 2022 spinoff); Pfizer exited $3B+ stake early 2025 with ADA Seal for Advil Dual Action dental pain competing with Tylenol and Aleve for OTC analgesic market.
Advil is a global over-the-counter ibuprofen pain relief brand — owned by Haleon plc (LSE: HLN / NYSE: HLN), the consumer healthcare company spun off from GSK on July 18, 2022, with Pfizer completing its full stake exit in early 2025 for $3+ billion — providing consumers with 23+ ibuprofen-based product varieties for pain, headache, cold, and sleep management including Advil Extra Strength, Advil Rapid Release Gels, Advil PM, Advil Dual Action (ibuprofen + acetaminophen), and Children's Advil. Advil entered the US market in 1984 (the first OTC ibuprofen in America, considered the "most famous prescription-to-OTC switch in history") and generates approximately $800 million+ annually as one of Haleon's flagship brands alongside Sensodyne, Panadol, Centrum, and Theraflu. In September 2024, Advil Dual Action became the first OTC pain reliever to earn the American Dental Association (ADA) Seal of Acceptance for temporary management of acute dental pain.
Japanese automaker with $89B revenue in Renault-Nissan Alliance; LEAF electric vehicle pioneer facing restructuring and Honda merger discussions amid China market and profit challenges.
Nissan Motor Co. is a Japanese multinational automobile manufacturer producing passenger cars, SUVs, trucks, and electric vehicles under the Nissan, Infiniti (luxury), and Mitsubishi (partnership) brands. Founded in 1933 in Yokohama, Japan and listed on the Tokyo Stock Exchange, Nissan generates approximately $89 billion (¥12.9 trillion) in annual revenue and is one of the world's largest automakers. Nissan has been part of the Renault-Nissan-Mitsubishi Alliance since 1999 — a cross-shareholding partnership that shares platforms, technology, and procurement.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.